Association of Hyperuricemia with Thrombosis in Philadelphia-Negative Chronic Myeloproliferative Neoplasms

被引:0
|
作者
Pulido, Mariem [1 ]
Aguilar, Elena Tuna [1 ]
Romero, Junice Teresita Sosa [2 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Hematol & Oncol Dept, Mexico City, Mexico
[2] Univ Nacl Autonoma Mexico, Fac Med, Ciudad Univ, Mexico City, Mexico
关键词
D O I
10.1182/blood-2024-203647
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:6637 / 6637
页数:1
相关论文
共 50 条
  • [31] Distinguishing atypical chronic myeloid leukemia from other Philadelphia-negative chronic myeloproliferative neoplasms
    Sadigh, Sam
    Hasserjian, Robert P.
    Hobbs, Gabriela
    CURRENT OPINION IN HEMATOLOGY, 2020, 27 (02) : 122 - 127
  • [32] IMPORTANCE OF COAGULATION ASSESSMENT IN PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS PATIENTS
    Kabat, M. Gasior
    Pollmar, M. I. Rivas
    Roman, M. T. Alvarez
    Manzano, E. Monzon
    Butta, P. Acuna
    Salgado, E. G. Arias
    Salces, M. Martin
    Giulinai, M. Facal
    Marugan, P. Gonzalez
    De Bustamante, J. Martin
    Serrano, L. Gomez
    Barcenilla, S. Garcia
    Castro, C. Ramos
    Coll, N. Butta
    Yuste, V. Jimenez
    HAEMOPHILIA, 2023, 29 : 166 - 166
  • [33] How we manage Philadelphia-negative myeloproliferative neoplasms in pregnancy
    Robinson, Susan E.
    Harrison, Claire N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (04) : 625 - 634
  • [34] Evaluation of thrombin generation in classical Philadelphia-negative myeloproliferative neoplasms
    Olteanu, Ariela Ligia
    Mihaila, Romeo-Gabriel
    Mihalache, Manuela
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2016, 24 (03): : 279 - 289
  • [35] Characteristics and outcomes of young adults with Philadelphia-negative myeloproliferative neoplasms
    Barzilai, Merav
    Kirgner, Ilya
    Avivi, Irit
    Ellis, Martin
    Dally, Najib
    Rozovski, Uri
    Lavi, Noa
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (06) : 504 - 508
  • [36] Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms
    Barbara Mora
    Francesco Passamonti
    Current Hematologic Malignancy Reports, 2022, 17 : 127 - 139
  • [37] EARLY EXPERIENCE WITH THE ESTABLISHMENT OF A REGISTRY FOR PHILADELPHIA-NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASMS (MPN) IN HUNGARY
    Dombi, P.
    Egyed, M.
    Illes, A.
    Demeter, J.
    Homor, L.
    Bodnar, M.
    Szerafin, L.
    Simon, Z.
    Udvardy, M.
    HAEMATOLOGICA, 2015, 100 : 757 - 757
  • [38] Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms
    Kaplan, Jason B.
    Stein, Brady L.
    McMahon, Brandon
    Giles, Francis J.
    Platanias, Leonidas C.
    EBIOMEDICINE, 2016, 3 : 17 - 25
  • [39] Proliferative characteristics of Philadelphia-negative myeloproliferative neoplasms - clinical implications
    Sefer, D.
    Bizic-Radulovic, S.
    Kraguljac-Kurtovic, N.
    Bogdanovic, A.
    Cokic, V.
    Miljic, P.
    Beleslin-Cokic, B.
    Knezevic, V.
    Mitrovic-Ajtic, O.
    Lekovic, D.
    Gotic, M.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 (01) : 21 - 31
  • [40] Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation
    Cacemiro, Maira da Costa
    Cominal, Jucara Gastaldi
    Tognon, Raquel
    Nunes, Natalia de Souza
    Simoes, Belinda Pinto
    de Figueiredo-Pontes, Lorena Lobo
    Bazzo Catto, Luiz Fernando
    Traina, Fabiola
    Souto, Elizabeth Xisto
    Zambuzi, Fabiana Albani
    Frantz, Fabiani Gai
    de Castro, Fabiola Attie
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2018, 40 (02) : 120 - 131